Abstract
INTRODUCTION
K eratoconus (KC) is a progressive type of non-inflammatory corneal degeneration characterized by stromal thinning and ectasia of the cornea leading to a decrease in visual acuity as a result of myopia, irregular astigmatism and corneal scarring [1] [2] . Various visual rehabilitation options are available including contact lenses, intracorneal ring segments (ICRS), phakic intraocular lenses (pIOL), and photorefractive keratectomy [3] . Corneal cross linking (CXL) can be combined with all of these techniques to stabilize KC [4] [5] [6] . The implantable collamer lens (ICL; Visian; STAAR Surgical, Nidau, Switzerland), which is used as a posterior chamber pIOL, is made from collamer, a biocompatible hydrophilic copolymer of collagen and hydroxyethyl methacrylate with an ultraviolet light-filtering chromophore [7] . A toric ICL is typically indicated for the correction of myopia in adults aged 21-40y with myopia up to -18.0 diopters (D) with up to 6.0 D of astigmatism. Toric ICL cannot correct irregular corneal astigmatism; therefore, it is an alternative method to correct myopia and myopic astigmatism in eyes with stable KC for partial visual rehabilitation [8] .
SUBJECTS AND METHODS Ethical Approval
The study complied the principles outlined in the Declaration of Helsinki. Written consent was obtained from all patients. None of our patients received any stipend. Clinical study registration number: ACTRN12618000909224. In this retrospective study, the visual and refractive outcomes of patients with KC who underwent ICL (STAAR Surgical Inc., Switzerland) implantation to correct myopia and myopic astigmatism were investigated. Patients were considered eligible if they were over 21y of age, had a stable refraction for 1y after CXL, contact lenses intolerant, and significant improvement in best corrected distance visual acuity (BCDVA) with refraction. Eligible patients had no other ocular and general pathology and no greater than stage 2 KC according to the Amsler-Krumeich classification [9] . Additional inclusion criteria were clear central cornea, central or centralized (with ICRS) cone, an anterior chamber depth (ACD) greater than 3.0 mm (from the endothelium), a mesopic pupil size of less than 6.5 mm. The lens power calculation was performed by online calculation software (STAAR Surgical Co., Switzerland). The calculation is based on: manifest refraction (the axis of astigmatism is the axis obtained by manifest refraction), corneal curvature, corneal thickness and ACD measured by 
s t-test, paired t-test
were used in analysis of this paper. P<0.05 was considered statistically significant.
RESULTS
The study included 14 eyes of 8 patients. The mean age was 29.6y (range: 21 to 44y). CXL was performed on ten eyes 
respectively).
There was no statistically significant difference in HOA (RMS) between before and after surgery (0.6±0.2 compared to 0.53± 0.3 respectively; Figure 3 ). Refractive Outcomes The mean preoperative manifest spherical equivalent (MSE) decreased from -4.8±2.25 to -0.3±0.4 D, which was statistically significant (P<0.01 highly significant). The mean preoperative manifest spherical error decreased from -3.7±1.9 to -0.2±0.5 D, which also was statistically significant (P<0.01 highly significant). The mean preoperative manifest astigmatism decreased significantly from -2.3±1.6 to -0.6±-0.5 D (P<0.01 highly significant). At 6mo after surgery our achieved mean SE was about 74% of our attempted mean SE. Sixty-five percent of eyes were within ±0.75 D of the attempted SE correction and 85% were within ±1.0 D of the attempted SE correction. DISCUSSION Corneal regularity is a very important factor for postoperative potential visual acuity. Highly aberrated eyes are accompanied with poor BCDVA and accordingly poor postoperative UCDVA. SRI is an indicator for corneal irregularity, which increase with increasing irregular astigmatism and is highly correlated with potential visual acuity. A toric ICL corrects only spherical and cylindrical errors of refraction, it cannot correct HOAs caused by an irregular corneal shape. Patients who have a good spectacle corrected visual acuity would benefit from toric ICL implantation. Cases who have a cornea that is too irregular to have a good corrected distance visual acuity (CDVA) except with rigid contact lenses, will not improve after toric ICL implantation. All our cases with K steep less than 52.0 D and SRI less than 1.5. Regarding effectiveness (preoperative BCDVA comparing with postoperative UCDVA), about 93% (13/14) of eyes maintained their same preoperative BCDVA or gained 1-2 lines, only 7% (1/14) of eyes lost one line of preoperative BCDVA (due to residual spherical error). No intraoperative or postoperative complication occurred. A toric ICL does not induce HOAs, since after toric ICL implantation, our patients still had the same amount of HOA despite correcting the high amount of myopia and myopic astigmatism. We were able to correct up to 6.5 D of myopia and up to 5.0 D of astigmatism with precise axis alignment.
Regarding predictability, at 6mo after surgery our achieved SE was about 74% of our attempted SE. Sixty-five percent of eyes were within ±0.75 D of the attempted SE correction and 85% were within ±1.0 D of the attempted SE correction.
Our study demonstrated a clinically significant improvement in postoperative UCDVA in all patients; this is in concurrence with the results of other studies [10] [11] [12] . About 50% of the eyes in our study maintained their preoperative BCDVA and 43% gained 1-2 lines, only 7% of eyes lost one line of BCDVA.
In a study by Kamiya et al [10] , 44% of their eyes showed no change in in BCDVA and 48% gain 1-2 lines and only 7% lost one line. A study by Navas et al [11] which had a long follow up period (38mo), showed that 9/11 (82%) of their eyes gained 1-3 lines of BCDVA, 1/11 (9%) presented no change and 1/11 (9%) lost one line. Kurian et al [12] In a study by Kurian et al [12] , the preoperative mean refractive SE decreased to -0.44±1.21 D at 6mo. Shafik Shaheen et al [13] had a postoperative SE of -0.25 D at 3y of follow up in 16 eyes that had early KC. Antonios et al [14] showed that the mean SE improved to -0.83±0.76 D. The mean cylinder also improved to 1.03±0.60 D and these values were maintained during the follow-up over 12mo. In a longer follow up period, Doroodgar et al [15] reported 82% of eyes were within ±0.50 D, and 97.05% were within ±1.0 D of attempted correction. Mean MSE was -0.07±0.5 and -0.01±0.48 D, at 1 and 4y respectively. None of their patients showed decrease in UCVA. Twenty-four eyes have increased in UCVA by ≥1 line. At 24mo follow up, Abdelmassih et al [16] concluded that UCVA improved significantly from 1.06 to 0.76 logMAR and the BCVA from 0.42 to 0.26 logMAR. Keratometric values and UCVA were stable, whereas BCVA, sphere, and cylinder values showed a significant improvement in the period between 6mo and 2y. In conclusion, implantation of the toric ICL was an effective, predictable and safe option to correct refractive error and to improve visual acuity in patients with stable KC and regular cornea. High corneal irregularity limits the potential visual acuity and may need another surgery to make the cornea more regular.
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